Tweaks To German Pharma Law Require Firms to Prove Drugs' Value Within a Year

Last-minute tweaks to Germany's pharmaceutical sector restructuring laws (AMNOG) require drug firms to provide evidence of a product's value within 12 months of launch – or risk having it struck off the reimbursement list.